KEVIN KOCH - President and CEO, Director at Edgewise Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
EWTX on Nasdaq
All Insider Reports
All Insider Reports

KEVIN KOCH - trading volume in the past year for Edgewise Therapeutics, Inc.

Holdings reported by KEVIN KOCH for Edgewise Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 259,554 $3,381,988 $13.03 12 Aug 2025 KTK Family Enterprise, LLC
Restricted Stock Units 87,500 $1,359,156 $18.91 12 Aug 2025 Direct Common Stock
Common Stock 30,615 $410,008 $13.39 12 Aug 2025 Direct
Common Stock 26,410 $344,122 $13.03 12 Aug 2025 Adrienne R. Koch Heritage Trust
Common Stock 26,410 $344,122 $13.03 12 Aug 2025 Matthew K. Koch Heritage Trust
Common Stock 26,410 $344,122 $13.03 12 Aug 2025 Nicole M. Soldow Heritage Trust
Stock Option (Right to Buy) 525,000 12 Aug 2025 Direct Common Stock

Transactions reported by KEVIN KOCH for Edgewise Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.